Response Biomedical

Response Biomedical is owned by Orbimed. Orbimed has a direct presence in 2 countries.

They are in:

• Fund50%
• Biotechnology50%

View the org chart displaying its 5 main executives

Most searched biographies at Response Biomedical

• Barbara Kinnaird, Chief Executive Officer, Director
• Angela Carter, Vice President, Global Channel Strategy
• Eric Whitters, Chief Operating Officer

Create your alert
to follow the executive moves at Response Biomedical.

Orbimed has 2,276 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Histogen has filed for bankruptcy protection  (posted on April 19 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on April 18 2024).
• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (posted on April 16 2024).

Popular contacts in Biotechnology

• Vik Bajaj - Director at Interline Therapeutics
• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Response Biomedical

• News & Events | Response Biomedical
• News & Events | Response Biomedical
• News & Events | Response Biomedical

Social media about Response Biomedical

• Response Biomedical on Wikipedia, Google News & Yahoo Finance
• Response Biomedical on LinkedIn, Twitter & YouTube

Contact by email its executives including Eric Whitters

Call Response Biomedical at +1 604...

View the org chart

Register to receive your alert

Report an error